Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Day One Biopharmaceuticals Inc DAWN

Healthcare Biotechnology
Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. The Company partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its product candidates include tovorafenib, pimasertib and the VRK1 program.... see more

Showcase News Releases

Showcase news

Benton Resources Inc.
Benton Identifies Deep Electro-Magnetic Anomaly on the Great Burnt Copper Deposit and Continues to Intersect Significant Gold in Drilling at South Pond
Bank of Montreal
BMO Ranks First in J.D. Power 2024 Canada Wealth Management Digital Experience Study
Silvercorp Metals Inc.
SILVERCORP ANNOUNCES CLOSING OF US$150 MILLION CONVERTIBLE SENIOR NOTES OFFERING

More Showcase News Releases »